|
Volumn 83, Issue 2, 1999, Pages 509-523
|
Neuroprotective therapies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTIOXIDANT;
ANTIPARKINSON AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
FREE RADICAL;
GLUTAMIC ACID;
LEVODOPA;
MONOAMINE OXIDASE B INHIBITOR;
NEUROTROPHIC FACTOR;
SELEGILINE;
TOCOPHEROL;
DISEASE COURSE;
DISEASE DURATION;
DRUG MECHANISM;
DRUG RESEARCH;
EARLY DIAGNOSIS;
HUMAN;
NEUROPROTECTION;
OXIDATIVE STRESS;
PARKINSON DISEASE;
PRIORITY JOURNAL;
REVIEW;
TREATMENT PLANNING;
|
EID: 0033059271
PISSN: 00257125
EISSN: None
Source Type: Journal
DOI: 10.1016/S0025-7125(05)70117-6 Document Type: Article |
Times cited : (33)
|
References (99)
|